ArticlePloS one2009

HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.

Maud Mavigner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.